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Introduction
Septic shock is associated with high mortality. Elderly
and multimorbid patients are not always eligible for
intensive care unit (ICU) admission. Intravenous (IV)
infusion of norepinephrine (NE) is an accepted treat-
ment for hypotension in septic shock. Use of a vasopres-
sor outside the ICU is poorly evaluated.
Objectives
To describe the severity of disease using Acute Physiology
and Chronic Health Evaluation (APACHE-II) scoring,
mortality and adverse events (AE); in patients with septic
shock receiving IV fluid and NE in a high dependency unit
(HDU) at the Dept of Medicine.
Methods
A retrospective review of 91 patients with sepsis treated
with antibiotics, IV fluids and NE for hypotension. Data
on HDU- and 30-day mortality, standardized mortality
ratio (SMR) as well as adverse events (necrosis and
arrhythmia) were collected. The route of administration
of fluids and NE, via peripheral venous catheter (PVC)
or central venous catheter (CVC), was registered. All
patients were monitored with pulse oximetry, a 3-point
ECG and had blood pressure measured non-invasively.
Nurse:patient ratio was ≥ 1:3 in the HDU.
Results
Median age (min-max) was 81 (43-96) years and median
APACHE-II was 26 (12-42) points. Patients not reaching a
mean arterial pressure (MAP) >65 mm Hg within
12 hours had poor outcome, see Figure 1. HDU-mortality
was 27 % (n = 25), with SMR as 0.443 (95 % CI: 0.287-
0.654); and 30-day mortality was 47 % (n = 43). NE (maxi-
mum 0.2 microgram/kg/min) was administered via PVC
in 87 % (n = 79) and via CVC in 13 % (n = 12) of patients,
duration up to 72 hours. No skin necrosis was noted; one
patient developed sinus tachycardia and died shortly after
having the NE-infusion stopped.
Conclusions
Patients treated with NE for hypotension in septic shock
had a better HDU survival than expected. This study
does not indicate frequent AEs when administering NE
via a PVC.
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Figure 1 Patient survival (%).
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